59th ASH Annual Meeting Wrap-up: Hotlanta Freezes Over
2017 ASH News Daily Editor-in-Chief Dr. Saad Usmani recaps the 2017 ASH annual meeting which took place in Atlanta.
Predicting Responses to Gemtuzumab Ozogamicin
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights from published articles in a convenient audio format. All of the podcasts are available for FREE! Learn more
Where to Listen
Listen to the podcasts below (Internet connection required) or download and listen to them later via SoundCloud or iTunes.
In this podcast, 2017 ASH News Daily Editor-in-Chief Dr. Saad Usmani has a conversation with Education Program Co-chair Dr. Laurie Sehn and Scientific Program Co-chair Dr. Andrew Weyrich about what to expect at the 59th ASH Annual Meeting and Exposition, taking place December 9-12, 2017, in Atlanta, Georgia. They talk about stimulating sessions to look forward to, new exciting features and features from previous years that are making their return such as the ASH White Board and Collaboration Rooms, as well as an array of networking events. Attendees will have the opportunity to connect with the top minds in the field of malignant and nonmalignant hematology as well as a global community of over 25,000 hematology professionals from every subspecialty. Learn more
In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Dr. Luisa Cimmino and Dr. Maher Abdul-Hay of NYU School of Medicine. They discuss Dr. Abdel-Wahab's Diffusion article, which appears in the November/December 2017 issue of The Hematologist, titled "Vitamin C Treatment Restores TET2-Deficiency and Confers Sensitivity to PARP Inhibition." This thought-provoking conversation touches on the use of vitamin C to restore TET2-deficiency in the treatment of leukemia. Read more
In this podcast, Outgoing Editor-in-Chief of The Hematologist Dr. Jason Gotlib gives a warm welcome to Editor-in-Chief Designee Dr. Laura Michaelis. Dr. Michaelis' term begins in 2018. They discuss her vision for the publication including The Hematologist's digital presence, multimedia efforts, new columns, and untapped topics that require attention. Learn more
In his Diffusion article from the September/October 2017 issue of The Hematologist, Dr. Jonathan Hoggatt discusses efforts to grow hematopoietic stem cells to care for patients with diseases that can be treated with bone marrow transplantation. He covers a Nature article co-authored by Dr. George Daley, Dean of Harvard Medical School. In this podcast, Dean Daley joins Dr. Hoggatt for a thought provoking conversation about these efforts. Read more
In this podcast, Drs. Adam Cuker, Holger Schünemann, Mary Cushman and Paul Monagle talk about new ASH Guidelines on VTE, an ASH project started in 2015 to develop 10 evidence-based clinical practice guidelines on the diagnosis and treatment of venous thromboembolism (VTE), in collaboration with the McMaster University GRADE center. Two of these 10 guidelines are now available for public comment, and these members of the panels urge you to provide your input by the deadline of August 25, 2017. Part 1 of the podcast features a conversation between Dr. Cuker and Dr. Schünemann (starting at 2:50 min), and Part 2 features Dr. Cushman conversing with Dr. Monagle (starting at 26:00 min). Comment here
November-December 2017Volume 14, Issue 6
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology